Osteoporosis Trial, Recruiting (NCT02719314)

Osteoporosis Trial, Recruiting NCT02719314 Sponsor: Prof Dr Frank Buttgereit Condition: Osteoporosis

Printed from Voxsanity (voxsanity.com.au) — NCT02719314 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoporosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a long-term inflammatory rheumatic disease or psoriasis (or, for the control group, you have not been diagnosed with these conditions)
You are currently taking, have previously taken, or are expected to start a long-term steroid (glucocorticoid) medication — this does not apply to control group participants
You attend or have been referred to the osteoporosis and bone metabolism clinic at the Charité hospital in Germany, following German osteoporosis guidelines
You are able to read and understand the information provided about the study
You agree to take part and allow your data to be stored

Who may not be able to join:

You have a dependency on alcohol, medications, and/or drugs
You have a severe psychiatric condition that would make it difficult to fully understand and follow the study
You are currently pregnant or breastfeeding
You are unable to give informed consent for any reason
You are a prisoner or are held in an institution under an official or court order

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Frank Buttgereit, Prof Dr, Charité University Medicine Berlin (CCM)

Phone: +49 30 450 513125

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02719314

Sponsor: Prof Dr Frank Buttgereit

Phase: Not Applicable

Status: Recruiting

Condition: Osteoporosis

Trial contact: +49 30 450 513125

More information: https://clinicaltrials.gov/study/NCT02719314

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a long-term inflammatory rheumatic disease or psoriasis (or, for the control group, you have not been diagnosed with these conditions)
You are currently taking, have previously taken, or are expected to start a long-term steroid (glucocorticoid) medication — this does not apply to control group participants
You attend or have been referred to the osteoporosis and bone metabolism clinic at the Charité hospital in Germany, following German osteoporosis guidelines
You are able to read and understand the information provided about the study
You agree to take part and allow your data to be stored

Who may not be able to join:

You have a dependency on alcohol, medications, and/or drugs
You have a severe psychiatric condition that would make it difficult to fully understand and follow the study
You are currently pregnant or breastfeeding
You are unable to give informed consent for any reason
You are a prisoner or are held in an institution under an official or court order

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Prof Dr Frank Buttgereit

Registry

ClinicalTrials.gov

Start date

1 December 2015

Est. completion

1 November 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Bone mineral density

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov